Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 3.82 % |
3 Month Return | + 23.84 % |
1 Year Return | + 58.51 % |
Market Stats | |
Previous Close | ₹37.25 |
Open | ₹38.36 |
Volume | 13.74K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹18.89Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹18.89 Cr |
P/B Ratio | 1.67 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 9.07 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹18.89 Cr | 135.53% | 0.69 | NA | NA | |
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Organisation | Beryl Drugs Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Beryl Drugs Ltd
Beryl Drugs Ltd shares started trading at Rs. 39.99 and hit a high of Rs. 40.99, gaining around 1%. The company's revenue decreased by 5%, but net profits increased by 15% in the December quarter. Beryl Drugs has delivered a multibagger of 212% to investors in one year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, Beryl Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 25.2%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 26.38% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 73.62% of holdings in Sep 2024 quarter
Price Dip
In the last 7 days, Beryl Drugs stock has moved down by -8.9%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 26.38% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 73.62% | 0.00 | |
Others | 0% | 0.00 |
Beryl Drugs Ltd’s net profit fell -30.19% since last year same period to ₹0.37Cr in the Q1 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 205.71% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Beryl Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Beryl Drugs Ltd (524606) share price today is ₹35.65
Beryl Drugs Ltd is not listed on NSE
Beryl Drugs Ltd is listed on BSE
Today’s traded volume of Beryl Drugs Ltd(524606) is 13.74K.
Today’s market capitalisation of Beryl Drugs Ltd(524606) is ₹18.89Cr.
Beryl Drugs Ltd(524606 | Price |
---|---|
52 Week High | ₹46 |
52 Week Low | ₹19.35 |
Beryl Drugs Ltd(524606) share price is ₹35.65. It is down -22.50% from its 52 Week High price of ₹46
Beryl Drugs Ltd(524606) share price is ₹35.65. It is up 84.24% from its 52 Week Low price of ₹19.35
Beryl Drugs Ltd(524606 | Returns |
---|---|
1 Day Returns | -1.6% |
1 Month Returns | 3.82% |
3 Month Returns | 23.84% |
1 Year Returns | 58.51% |